"Pneumococcal Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
| Descriptor ID |
D022242
|
| MeSH Number(s) |
D20.215.894.135.750.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pneumococcal Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Pneumococcal Vaccines".
This graph shows the total number of publications written about "Pneumococcal Vaccines" by people in this website by year, and whether "Pneumococcal Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 1 | 4 |
| 2006 | 5 | 2 | 7 |
| 2007 | 4 | 1 | 5 |
| 2008 | 4 | 0 | 4 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 4 | 1 | 5 |
| 2012 | 4 | 2 | 6 |
| 2013 | 4 | 2 | 6 |
| 2014 | 8 | 1 | 9 |
| 2015 | 4 | 3 | 7 |
| 2016 | 2 | 3 | 5 |
| 2017 | 11 | 3 | 14 |
| 2018 | 3 | 3 | 6 |
| 2019 | 5 | 4 | 9 |
| 2020 | 6 | 5 | 11 |
| 2021 | 5 | 2 | 7 |
| 2022 | 1 | 3 | 4 |
| 2023 | 0 | 7 | 7 |
| 2024 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pneumococcal Vaccines" by people in Profiles.
-
Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
-
Geographical migration and fitness dynamics of Streptococcus pneumoniae. Nature. 2024 Jul; 631(8020):386-392.
-
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis. Health Technol Assess. 2024 Jul; 28(34):1-109.
-
Impact of nutritional status on vaccine-induced immunity in children living in South Africa: Investigating the B-cell repertoire and metabolic hormones. Vaccine. 2024 May 22; 42(14):3337-3345.
-
Nanofluidic qPCR unable to detect and serotype Streptococcus pneumoniae in urine samples of hospitalized South African patients with community-acquired pneumonia. Sci Rep. 2023 12 04; 13(1):21332.
-
Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children. Int J Infect Dis. 2023 Sep; 134:45-52.
-
Optimization of a high-throughput nanofluidic real-time PCR to detect and quantify of 15 bacterial species and 92 Streptococcus pneumoniae serotypes. Sci Rep. 2023 03 21; 13(1):4588.
-
A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV. AIDS. 2023 07 01; 37(8):1227-1237.
-
Optimal age targeting for pneumococcal vaccination in older adults; a modelling study. Nat Commun. 2023 02 16; 14(1):888.
-
Unmasking Pneumococcal Carriage in a High Human Immunodeficiency Virus (HIV) Prevalence Population in two Community Cohorts in South Africa, 2016-2018: The PHIRST Study. Clin Infect Dis. 2023 02 08; 76(3):e710-e717.